Snapshots of actin and tubulin folding inside the TRiC chaperonin.


Journal

Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374

Informations de publication

Date de publication:
05 2022
Historique:
received: 07 03 2021
accepted: 01 03 2022
pubmed: 23 4 2022
medline: 20 5 2022
entrez: 22 4 2022
Statut: ppublish

Résumé

The integrity of a cell's proteome depends on correct folding of polypeptides by chaperonins. The chaperonin TCP-1 ring complex (TRiC) acts as obligate folder for >10% of cytosolic proteins, including he cytoskeletal proteins actin and tubulin. Although its architecture and how it recognizes folding substrates are emerging from structural studies, the subsequent fate of substrates inside the TRiC chamber is not defined. We trapped endogenous human TRiC with substrates (actin, tubulin) and cochaperone (PhLP2A) at different folding stages, for structure determination by cryo-EM. The already-folded regions of client proteins are anchored at the chamber wall, positioning unstructured regions toward the central space to achieve their native fold. Substrates engage with different sections of the chamber during the folding cycle, coupled to TRiC open-and-close transitions. Further, the cochaperone PhLP2A modulates folding, acting as a molecular strut between substrate and TRiC chamber. Our structural snapshots piece together an emerging model of client protein folding within TRiC.

Identifiants

pubmed: 35449234
doi: 10.1038/s41594-022-00755-1
pii: 10.1038/s41594-022-00755-1
pmc: PMC9113939
doi:

Substances chimiques

Actins 0
Peptides 0
Tubulin 0
Chaperonin Containing TCP-1 EC 3.6.1.-
Chaperonins EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

420-429

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17137
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 092809/Z/10/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Yam, A. Y. et al. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nat. Struct. Mol. Biol. 15, 1255–1262 (2008).
pubmed: 19011634 pmcid: 2658641 doi: 10.1038/nsmb.1515
Thulasiraman, V., Yang, C. F. & Frydman, J. In vivo newly translated polypeptides are sequestered in a protected folding environment. EMBO J. 18, 85–95 (1999).
pubmed: 9878053 pmcid: 1171105 doi: 10.1093/emboj/18.1.85
Camasses, A., Bogdanova, A., Shevchenko, A. & Zachariae, W. The CCT chaperonin promotes activation of the anaphase-promoting complex through the generation of functional Cdc20. Mol. Cell 12, 87–100 (2003).
pubmed: 12887895 doi: 10.1016/S1097-2765(03)00244-2
Wang, D. Y., Kamuda, K., Montoya, G. & Mesa, P. The TRiC/CCT chaperonin and its role in uncontrolled proliferation. Adv. Exp. Med. Biol. 1243, 21–40 (2020).
pubmed: 32297209 doi: 10.1007/978-3-030-40204-4_2
Shahmoradian, S. H. et al. TRiC’s tricks inhibit huntingtin aggregation. eLife 2, e00710 (2013).
pubmed: 23853712 pmcid: 3707056 doi: 10.7554/eLife.00710
Sot, B. et al. The chaperonin CCT inhibits assembly of α-synuclein amyloid fibrils by a specific, conformation-dependent interaction. Sci. Rep. 7, 40859 (2017).
pubmed: 28102321 pmcid: 5244355 doi: 10.1038/srep40859
Knowlton, J. J. et al. The TRiC chaperonin controls reovirus replication through outer-capsid folding. Nat. Microbiol. 3, 481–493 (2018).
pubmed: 29531365 pmcid: 5874176 doi: 10.1038/s41564-018-0122-x
Banks, C. A. S. et al. Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly. Sci. Rep. 8, 1–13 (2018).
doi: 10.1038/s41598-018-32009-w
Dekker, C. et al. The crystal structure of yeast CCT reveals intrinsic asymmetry of eukaryotic cytosolic chaperonins. EMBO J. 30, 3078–3090 (2011).
pubmed: 21701561 pmcid: 3160183 doi: 10.1038/emboj.2011.208
Muñoz, I. G. et al. Crystal structure of the open conformation of the mammalian chaperonin CCT in complex with tubulin. Nat. Struct. Mol. Biol. 18, 14–20 (2011).
pubmed: 21151115 doi: 10.1038/nsmb.1971
Cong, Y. et al. 4.0-Å resolution cryo-EM structure of the mammalian chaperonin TRiC/CCT reveals its unique subunit arrangement. Proc. Natl Acad. Sci. USA 107, 4967–4972 (2010).
pubmed: 20194787 pmcid: 2841888 doi: 10.1073/pnas.0913774107
Spiess, C., Meyer, A. S., Reissmann, S. & Frydman, J. Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. Trends Cell Biol. 14, 598–604 (2004).
pubmed: 15519848 pmcid: 2812437 doi: 10.1016/j.tcb.2004.09.015
Cong, Y. et al. Symmetry-free cryo-EM structures of the chaperonin TRiC along its ATPase-driven conformational cycle. EMBO J. 31, 720–730 (2012).
pubmed: 22045336 doi: 10.1038/emboj.2011.366
Joachimiak, L. A., Walzthoeni, T., Liu, C. W., Aebersold, R. & Frydman, J. The structural basis of substrate recognition by the eukaryotic chaperonin TRiC/CCT. Cell 159, 1042–1055 (2014).
pubmed: 25416944 pmcid: 4298165 doi: 10.1016/j.cell.2014.10.042
Jiang, Y. et al. Sensing cooperativity in ATP hydrolysis for single multisubunit enzymes in solution. Proc. Natl Acad. Sci. USA 108, 16962–16967 (2011).
pubmed: 21896715 pmcid: 3193194 doi: 10.1073/pnas.1112244108
Reissmann, S. et al. A gradient of ATP affinities generates an asymmetric power stroke driving the chaperonin TRIC/CCT folding cycle. Cell Rep. 2, 866–877 (2012).
pubmed: 23041314 pmcid: 3543868 doi: 10.1016/j.celrep.2012.08.036
Amit, M. et al. Equivalent mutations in the eight subunits of the chaperonin CCT produce dramatically different cellular and gene expression phenotypes. J. Mol. Biol. 401, 532–543 (2010).
pubmed: 20600117 doi: 10.1016/j.jmb.2010.06.037
Zang, Y. et al. Staggered ATP binding mechanism of eukaryotic chaperonin TRiC (CCT) revealed through high-resolution cryo-EM. Nat. Struct. Mol. Biol. 23, 1083–1091 (2016).
pubmed: 27775711 doi: 10.1038/nsmb.3309
Lopez, T., Dalton, K., Tomlinson, A., Pande, V. & Frydman, J. An information theoretic framework reveals a tunable allosteric network in group II chaperonins. Nat. Struct. Mol. Biol. 24, 726–733 (2017).
pubmed: 28741612 pmcid: 5986071 doi: 10.1038/nsmb.3440
Dobrzynski, J. K., Sternlicht, M. L., Peng, I., Farr, G. W. & Sternlicht, H. Evidence that beta-tubulin induces a conformation change in the cytosolic chaperonin which stabilizes binding: implications for the mechanism of action. Biochemistry 39, 3988–4003 (2000).
pubmed: 10747787 doi: 10.1021/bi992110s
Yébenes, H., Mesa, P., Muñoz, I. G., Montoya, G. & Valpuesta, J. M. Chaperonins: two rings for folding. Trends Biochem. Sci. 36, 424–432 (2011).
pubmed: 21723731 doi: 10.1016/j.tibs.2011.05.003
Gestaut, D., Limatola, A., Joachimiak, L. & Frydman, J. The ATP-powered gymnastics of TRiC/CCT: an asymmetric protein folding machine with a symmetric origin story. Curr. Opin. Struct. Biol. 55, 50–58 (2019).
pubmed: 30978594 pmcid: 6776438 doi: 10.1016/j.sbi.2019.03.002
Pollard, T. D., Blanchoin, L. & Mullins, R. D. Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu. Rev. Biophys. Biomol. Struct. 29, 545–576 (2000).
pubmed: 10940259 doi: 10.1146/annurev.biophys.29.1.545
Costa, C. F. Myopathy mutations in alpha-skeletal-muscle actin cause a range of molecular defects. J. Cell Sci. 117, 3367–3377 (2004).
pubmed: 15226407 doi: 10.1242/jcs.01172
Gestaut, D. et al. The chaperonin TRiC/CCT associates with prefoldin through a conserved electrostatic interface essential for cellular proteostasis article the chaperonin TRiC/CCT associates with prefoldin through a conserved electrostatic interface essential for cellular proteostasis. Cell 177, 751–765 (2019).
pubmed: 30955883 pmcid: 6629582 doi: 10.1016/j.cell.2019.03.012
Willardson, B. M. & Howlett, A. C. Function of phosducin-like proteins in G protein signaling and chaperone-assisted protein folding. Cell Signal 19, 2417–2427 (2007).
pubmed: 17658730 pmcid: 2095786 doi: 10.1016/j.cellsig.2007.06.013
Sergeeva, O. A. et al. Human CCT4 and CCT5 chaperonin subunits expressed in Escherichia coli form biologically active homo-oligomers. J. Biol. Chem. 288, 17734–17744 (2013).
pubmed: 23612981 pmcid: 3682573 doi: 10.1074/jbc.M112.443929
Dalvai, M. et al. A scalable genome-editing-based approach for mapping multiprotein complexes in human cells. Cell Rep. 13, 621–633 (2015).
pubmed: 26456817 doi: 10.1016/j.celrep.2015.09.009
Dobrzynski, J. K., Sternlicht, M. L., Farr, G. W. & Sternlicht, H. Newly-synthesized β-tubulin demonstrates domain-specific interactions with the cytosolic chaperonin. Biochemistry 35, 15870–15882 (1996).
pubmed: 8961952 doi: 10.1021/bi961114j
Knowlton, J. J. et al. Structural and functional dissection of reovirus capsid folding and assembly by the prefoldin-TRiC/CCT chaperone network. Proc. Natl Acad. Sci. USA 118, e2018127118 (2021).
pubmed: 33836586 pmcid: 7980406 doi: 10.1073/pnas.2018127118
Kalisman, N., Adams, C. M. & Levitt, M. Subunit order of eukaryotic TRiC/CCT chaperonin by cross-linking, mass spectrometry, and combinatorial homology modeling. Proc. Natl Acad. Sci. USA 109, 2884–2889 (2012).
pubmed: 22308438 pmcid: 3287007 doi: 10.1073/pnas.1119472109
Leitner, A. et al. The molecular architecture of the eukaryotic chaperonin TRiC/CCT. Structure 20, 814–825 (2012).
pubmed: 22503819 pmcid: 3350567 doi: 10.1016/j.str.2012.03.007
Kalisman, N., Schröder, G. F. & Levitt, M. The crystal structures of the eukaryotic chaperonin CCT reveal its functional partitioning. Structure 21, 540–549 (2013).
pubmed: 23478063 pmcid: 3622207 doi: 10.1016/j.str.2013.01.017
Jin, M. et al. An ensemble of cryo-EM structures of TRiC reveal its conformational landscape and subunit specificity. Proc. Natl Acad. Sci. USA 116, 19513–19522 (2019).
pubmed: 31492816 pmcid: 6765261 doi: 10.1073/pnas.1903976116
Zhang, J. et al. Cryo-EM structure of a group II chaperonin in the prehydrolysis ATP-bound state leading to lid closure. Structure 19, 633–639 (2011).
pubmed: 21565698 pmcid: 3705922 doi: 10.1016/j.str.2011.03.005
Ilca, S. L. et al. Multiple liquid crystalline geometries of highly compacted nucleic acid in a dsRNA virus. Nature 570, 252–256 (2019).
pubmed: 31142835 doi: 10.1038/s41586-019-1229-9
Nogales, E., Wolf, S. G. & Downing, K. H. Structure of the αβ tubulin dimer by electron crystallography. Nature 391, 199–203 (1998).
pubmed: 9428769 doi: 10.1038/34465
Stirling, P. C. et al. PhLP3 modulates CCT-mediated actin and tubulin folding via ternary complexes with substrates. J. Biol. Chem. 281, 7012–7021 (2006).
pubmed: 16415341 doi: 10.1074/jbc.M513235200
Lou, X., Bao, R., Zhou, C. Z. & Chen, Y. Structure of the thioredoxin-fold domain of human phosducin-like protein 2. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 65, 67–70 (2009).
pubmed: 19193988 pmcid: 2635858 doi: 10.1107/S1744309108037342
Mendes, M. L. et al. An integrated workflow for crosslinking mass spectrometry. Mol. Syst. Biol. 15, 1–13 (2019).
doi: 10.15252/msb.20198994
Zamel, J., Cohen, S., Zohar, K. & Kalisman, N. Facilitating in situ cross-linking and mass spectrometry by antibody-based protein enrichment. J. Proteome Res. 20, 3701–3708 (2021).
pubmed: 34151562 doi: 10.1021/acs.jproteome.1c00269
Cuéllar, J. et al. Structural and functional analysis of the role of the chaperonin CCT in mTOR complex assembly. Nat. Commun. 10, 1–14 (2019).
doi: 10.1038/s41467-019-10781-1
Balchin, D., Mili, G., Strauss, M., Hayer-hartl, M. & Hartl, F. U. Pathway of actin folding directed by the eukaryotic chaperonin TRiC. Cell 174, 1507–1521 (2018).
pubmed: 30100183 doi: 10.1016/j.cell.2018.07.006
Llorca, O. et al. The ‘sequential allosteric ring’ mechanism in the eukaryotic chaperonin-assisted folding of actin and tubulin. EMBO J. 20, 4065–4075 (2001).
pubmed: 11483510 pmcid: 149171 doi: 10.1093/emboj/20.15.4065
Douglas, N. R. et al. Dual action of ATP hydrolysis couples lid closure to substrate release into the group II chaperonin chamber. Cell 144, 240–252 (2011).
pubmed: 21241893 pmcid: 3055171 doi: 10.1016/j.cell.2010.12.017
Ferreyra, R. G. & Frydman, J. Purification of the cytosolic chaperonin TRiC from bovine testis. Chaperonin Protoc. 140, 153–160 (2003).
doi: 10.1385/1-59259-061-6:153
Liou, A. K. F. & Willison, K. R. Elucidation of the subunit orientation in CCT (chaperonin containing TCP1) from the subunit composition of CCT micro-complexes. EMBO J. 16, 4311–4316 (1997).
pubmed: 9250675 pmcid: 1170057 doi: 10.1093/emboj/16.14.4311
Pappenberger, G., Mccormack, E. A. & Willison, K. R. Quantitative actin folding reactions using yeast CCT purified via an internal tag in the CCT3/γ subunit. J. Mol. Biol. 360, 484–496 (2006).
pubmed: 16762366 doi: 10.1016/j.jmb.2006.05.003
McCormack, E. A., Altschuler, G. M., Dekker, C., Filmore, H. & Willison, K. R. Yeast phosducin-like protein 2 acts as a stimulatory co-factor for the folding of actin by the chaperonin CCT via a ternary complex. J. Mol. Biol. 391, 192–206 (2009).
pubmed: 19501098 doi: 10.1016/j.jmb.2009.06.003
Zakeri, B. et al. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc. Natl Acad. Sci. USA 109, e690–e697 (2012).
pubmed: 22366317 pmcid: 3311370 doi: 10.1073/pnas.1115485109
Agudelo, D. et al. Marker-free coselection for CRISPR-driven genome editing in human cells. Nat. Methods 14, 615–620 (2017).
pubmed: 28417998 doi: 10.1038/nmeth.4265
Pardon, E. et al. A general protocol for the generation of Nanobodies for structural biology. Nat. Protoc. 9, 674–693 (2014).
pubmed: 24577359 pmcid: 4297639 doi: 10.1038/nprot.2014.039
de la Rosa-Trevin, J. M. et al. Scipion: A software framework toward integration, reproducibility and validation in 3D electron microscopy. J. Struct. Biol. 195, 93–99 (2016).
pubmed: 27108186 doi: 10.1016/j.jsb.2016.04.010
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038 doi: 10.1038/nmeth.4193
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
pubmed: 26278980 pmcid: 6760662 doi: 10.1016/j.jsb.2015.08.008
Scheres, S. H. W. RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).
pubmed: 23000701 pmcid: 3690530 doi: 10.1016/j.jsb.2012.09.006
Kimanius, D., Forsberg, B. O., Scheres, S. H. W. & Lindahl, E. Accelerated cryo-EM structure determination with parallelisation using GPUS in RELION-2. eLife 5, 1–21 (2016).
doi: 10.7554/eLife.18722
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, 1–22 (2018).
doi: 10.7554/eLife.42166
Abrishami, V. et al. Localized reconstruction in Scipion expedites the analysis of symmetry mismatches in cryo-EM data. Prog. Biophys. Mol. Biol. 160, 43–52 (2021).
pubmed: 32470354 doi: 10.1016/j.pbiomolbio.2020.05.004
Topf, M. et al. Protein structure fitting and refinement guided by cryo-EM density. Structure 16, 295–307 (2008).
pubmed: 18275820 pmcid: 2409374 doi: 10.1016/j.str.2007.11.016
Joseph, A. P. et al. Refinement of atomic models in high resolution EM reconstructions using Flex-EM and local assessment. Methods 100, 42–49 (2016).
pubmed: 26988127 pmcid: 4854230 doi: 10.1016/j.ymeth.2016.03.007
Kubota, H., Hynes, G. M., Kerr, S. M. & Willison, K. R. Tissue-specific subunit of the mouse cytosolic chaperonin-containing TCP-1. FEBS Lett. 402, 53–56 (1997).
pubmed: 9013858 doi: 10.1016/S0014-5793(96)01501-3
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910 doi: 10.1038/nbt.1511
Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteom. 13, 2513–2526 (2014).
doi: 10.1074/mcp.M113.031591
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).
pubmed: 27348712 doi: 10.1038/nmeth.3901

Auteurs

John J Kelly (JJ)

Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Dale Tranter (D)

Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland.

Els Pardon (E)

Structural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
VIB-VUB Center for Structural Biology, VIB, Brussels, Belgium.

Gamma Chi (G)

Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Holger Kramer (H)

Biological Mass Spectrometry and Proteomics Facility, MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK.

Lotta Happonen (L)

Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden.

Kelly M Knee (KM)

Pfizer Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.

Jay M Janz (JM)

Pfizer Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.

Jan Steyaert (J)

Structural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
VIB-VUB Center for Structural Biology, VIB, Brussels, Belgium.

Christine Bulawa (C)

Pfizer Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA.

Ville O Paavilainen (VO)

Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland.

Juha T Huiskonen (JT)

Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland. juha.huiskonen@helsinki.fi.
Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland. juha.huiskonen@helsinki.fi.
Division of Structural Biology, Wellcome Centre for Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK. juha.huiskonen@helsinki.fi.

Wyatt W Yue (WW)

Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. wyatt.yue@cmd.ox.ac.uk.
Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne, UK. wyatt.yue@cmd.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH